SBC Medical Group Holdings Incorporated (SBC)
NASDAQ: SBC · Real-Time Price · USD
4.440
+0.180 (4.23%)
Apr 16, 2025, 10:22 AM EDT - Market open

SBC Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Revenue
205.42193.54174.16
Revenue Growth (YoY)
6.13%11.13%-
Cost of Revenue
49.3756.2482.16
Gross Profit
156.05137.392
Selling, General & Admin
57.0764.3370.09
Other Operating Expenses
0.62.311.54
Operating Expenses
70.6966.6471.63
Operating Income
85.3670.6620.37
Interest Expense
-0.03-0.05-0.03
Interest & Investment Income
0.020.090.47
Other Non Operating Income (Expenses)
2.492.653.88
EBT Excluding Unusual Items
87.8573.3624.69
Impairment of Goodwill
---0.25
Gain (Loss) on Sale of Investments
-3.150.22-0.76
Gain (Loss) on Sale of Assets
3.81--
Asset Writedown
-15.06--
Pretax Income
73.4673.5823.68
Income Tax Expense
26.7735.0218.12
Earnings From Continuing Operations
46.6938.565.55
Minority Interest in Earnings
-0.080.810.76
Net Income
46.6139.376.32
Net Income to Common
46.6139.376.32
Net Income Growth
18.40%523.44%-
Shares Outstanding (Basic)
97948
Shares Outstanding (Diluted)
97948
Shares Change (YoY)
2.51%1084.96%-
EPS (Basic)
0.480.420.79
EPS (Diluted)
0.480.420.79
EPS Growth
15.50%-47.39%-
Free Cash Flow
17.1741.15-24.99
Free Cash Flow Per Share
0.180.44-3.14
Gross Margin
75.97%70.94%52.83%
Operating Margin
41.56%36.51%11.70%
Profit Margin
22.69%20.34%3.63%
Free Cash Flow Margin
8.36%21.26%-14.35%
EBITDA
89.1682.9126.3
EBITDA Margin
43.41%42.84%15.10%
D&A For EBITDA
3.812.255.93
EBIT
85.3670.6620.37
EBIT Margin
41.56%36.51%11.70%
Effective Tax Rate
36.44%47.59%76.55%
Revenue as Reported
205.42193.54174.16
Advertising Expenses
2.783.376.57
Updated Mar 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q